Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Smith & Nephew (NYSE:SNN) through any online brokerage.
Other companies in Smith & Nephew’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Smith & Nephew has a consensus price target of $31.88.
The stock price for Smith & Nephew (NYSE: SNN) is $26.575 last updated October 1, 2026 at 3:50 PM EDT.
There are no upcoming dividends for Smith & Nephew.
Smith & Nephew does not have any upcoming earnings scheduled.
There is no upcoming split for Smith & Nephew.
Smith & Nephew is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.